Skip to main content
News Archive

Bayer HealthCare, Johns Hopkins collaborate, GSK invests $95M in cell research (Morning Read) – MedCity NewsMedCity News

By June 17, 2015May 22nd, 2025No Comments

johns-hopkins-logo

Bayer HealthCare and Johns Hopkins University entered into a five-year collaboration to develop ophthalmic therapies that target retinal diseases. They will work together on discovery and development of drugs for treatment of eye diseases such as age-related macular degeneration and diabetic macular edema, among others.

{iframe}http://medcitynews.com/2015/06/latest-healthcare-innovations-for-61715-morning-read/{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.